Speaker illustration

Doctor Yuichi J Shimada

Columbia University Medical Center, New York (United States of America)

Prediction of major adverse cardiovascular events in patients with hypertrophic cardiomyopathy using proteomics profiling

Event: ESC Congress 2021 - The Digital Experience

Topic: Hypertrophic Cardiomyopathy

Session: Frontiers in prognostic research in hypertrophic cardiomyopathy

Thumbnail

Comprehensive proteomics profiling reveals molecular pathways that are differentially regulated in hypertrophic cardiomyopathy and correlate with clinical markers of disease severity

Event: ESC Congress 2021 - The Digital Experience

Topic: Hypertrophic Cardiomyopathy

Session: Myocardial and pericardial disease e-posters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb